award

A Phase II Study Evaluating the Safety and Efficacy of Whole-Cell Pneumococcal Vaccine (wSp) in Reducing Nasopharyngeal Colonization by Streptococcus pneumoniae in Young Children

  • Award Number: U01AI172733

  • ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

  • OPDIV: NIH

  • AWARD CLASS: COOPERATIVE AGREEMENT

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

  • PERIOD OF PERFORMANCE START DATE: 03/15/2024

  • PERIOD OF PERFORMANCE END DATE: 02/29/2028